Anesthesia, Colonoscopy and Co-Pays

There’s a new update on colonoscopy coverage! Guidance from Health and Human Services (HHS) indicates that issuers cannot impose cost-sharing for anesthesia services performed in connection with preventive colonoscopies. We’ll break it down a little bit… The Background Since the implementation of the Affordable Care Act (ACA), there has been confusion about preventive colorectal cancer screening and costs.…  Read More

PACES Trial S0820 – CRC CLINICAL TRIAL UPDATE

Since the inception of Fight Colorectal Cancer (Fight CRC), we have advocated for and supported cancer research. Today kicks off the first off many blogs where I will update you on the latest clinical trials for colorectal cancer research. Learn the process of clinical trials. NCI’s Colon Task Force First – some background. Nancy Roach, our founder…  Read More

Ramucirumab – A New Treatment Option

The FDA approved the use of the drug ramucirumab (brand name Cyramza®) on April 24, 2015 for patients with metastatic colorectal cancer in combination with FOLFIRI. Ramucirumab with FOLFIRI is now approved for patients whose cancer has progressed during or after treatment with first line therapies (typically FOLFOX and bevacizumab (Avastin®). Ramucirumab was approved after the…  Read More

Our Response & Action to the CDC’s Ostomy Ads

Thanks to the many advocates voicing their opinions through social media, I decided to pick up the phone and call the American Cancer Society (ACS) and The Centers for Disease Control and Prevention (CDC) last week regarding the new round of ads that are a part of the “Tips From Former Smokers“ campaign. This public health…  Read More

Meet Lisa Fund Researcher: Dr. Noel FCC de Miranda

Fight Colorectal Cancer is thrilled to introduce the newest Lisa Fund award recipient, Dr. Noel FCC de Miranda. Dr. de Miranda has been awarded the 2015 Fight Colorectal Cancer-Michael’s Mission-AACR Fellowship to research early onset (under 50), late-stage colorectal cancer. This two-year grant will begin in July and will focus on increasing the ability of immune…  Read More

Immunotherapy & Colorectal Cancer – Part 2

Yesterday in Immunotherapy for Colorectal Cancer : Part 1 we covered the basics of immunotherapy and the definitions of active and passive treatments. Today we provide insights for current research & what’s on the horizon for immunotherapy for colon and rectal cancer patients. Here’s where we are Passive immunotherapy (defined in yesterday’s blog) has significantly impacted colorectal cancer treatment with targeted…  Read More